Message to Shareholders and Investors

Message

One of the Alfresa Group’s principles is expressed in Our Philosophy, which is to create and deliver a fresh life for all. Another such principle is expressed in Our Vision, which is to become a Healthcare Consortium that provides products and services in every health-related field. Guided by these principles, we strive for safe, secure, and sincere business activities while pursuing sustainability management with the dual aim of delivering a sustainable society and continuously improving corporate value.

In May 2023, we established the Alfresa Group’s Medium- to Long-Term Vision. This vision commits us to securing profit growth by enhancing the profitability of core businesses and to expanding the revenue of growth and new businesses, as well as enhancing and expanding total supply chain services.

April 2025 saw the start of 25-27 Mid-term Management Plan Vision 2032 Stage 2 “Pioneering the Future with Our Collective Strength,” which is positioned as the second stage in our efforts to achieve the goals of the Medium- to Long-Term Vision. In light of changes in the business environment, including rising logistics and labor costs, soaring energy prices, and annual National Health Insurance (NHI) drug price revisions, we will take on new challenges by not only strengthening the competitiveness of our core businesses but also by strategically investing in growth and new businesses, while maintaining thorough cost control. We will evolve our total supply chain services, which provide group-wide services from introduction, development, and manufacturing of medicines to its distribution, sales, and post-marketing surveillance, leading to the sustainable growth of the group and the creation of social value.

I thank you for your valued investment in our company and I hope that you will continue to support us in the years ahead.